Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Attending-Level Neurologists at Academic Medical Centers (US)(?)

Council Members in this Study Group: 549

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Josef Parvizi, MD, Attending Neurologist, Stanford University Medical CenterJosef Parvizi, MD
Attending Neurologist
Stanford University Medical Center

Josef Parvizi, MD, PhD, is an Assistant Professor of Neurological Sciences at Stanford University. Dr. Parvizi has main interest in analyzing the design and results of new clinical trials, of medications or devices, in various fields of neurology. He has clinical expertise in Alzheimer's disease, neuropathic...

Stephen Landy, MD
Director of Neurology
Wesley Headache Clinic

Stephen Landy, MD, is the Director of Neurology at Wesley Headache Clinic and Clinical Professor in Department of Neurology at University of Tennessee. Dr. Landy is certified by the National Board of Medical Examiners, the American Board of Psychiatry and Neurolgy. Also, he is certified by the National...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
The Devil Is in the Details | 09-01-2008
Author: GLG Expert Contributor

This large study shows that PD patients' severity of motor dysfunction is better on rasagiline than on placebo.

Concerns about the Rember Phase 2 data | 08-06-2008
Author: GLG Expert Contributor

While the clinical trial data remain unpublished, those who attended the ICAD conference remain concerned about the possibility that the effects are not as pronounced as the interpretation by the investigators.

Another reason to use Lipitor | 04-04-2008
Author: GLG Expert Contributor

Lipitor is the only statin tested to reduce ischemic stroke. The new study also proved its role in reduce angina and MI

Another attack to Merck | 04-03-2008
Analysis of: Merck’s New Cholesterol Pill Has Mixed Results | www.pharmalot.com
Author: GLG Expert Contributor

The potential side effect of liver damage of the new cholesterol agent from Merck will definitely slow or even halt the FDA approval of the medication.

Potential new medication in the fight against AD | 04-01-2008
Author: GLG Expert Contributor

LY450139 acts through decrease the production of amyloid beta, the protein found in some of AD pathology. This novel mechanism of action carries the hope of halting disease progression.

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Physician - Division Head
  • Physician - Department Chair

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-09-06T21:45:17.077